📊 AVAH Key Takeaways
Is Aveanna Healthcare Holdings, Inc. (AVAH) a Good Investment?
Aveanna demonstrates solid operational performance with strong 20.2% revenue growth and healthy profitability metrics, but faces concerning leverage with a 6.68x debt-to-equity ratio and weak interest coverage of 1.8x. The exceptional 115.7% ROE is artificially inflated by minimal equity base rather than operational excellence, masking underlying financial stress from high debt levels.
Aveanna shows solid top-line momentum, healthy gross and operating margins, and positive free cash flow generation, which indicates the core business is scaling profitably. However, flat net income despite 20.2% revenue growth, very high leverage, and weak interest coverage materially constrain financial flexibility and reduce the quality of the earnings profile. The fundamentals support a balanced view: operationally improved, but still burdened by debt risk.
Why Buy Aveanna Healthcare Holdings, Inc. Stock? AVAH Key Strengths
- Strong revenue growth of 20.2% YoY indicating market expansion in home healthcare
- Solid profitability with 33.3% gross margin and 10.2% operating margin showing pricing power
- Positive free cash flow of $117.1M (4.8% FCF margin) with capex discipline
- Adequate liquidity with 1.32x current ratio supporting operational needs
- Revenue growth of 20.2% YoY with positive operating leverage
- Gross margin of 33.3% and operating margin of 10.5% indicate a profitable core business
- Positive operating cash flow of $125.86M and free cash flow of $117.06M support liquidity
AVAH Stock Risks: Aveanna Healthcare Holdings, Inc. Investment Risks
- Dangerously high leverage at 6.68x debt-to-equity ratio with $1.3B long-term debt against $194.5M equity
- Weak interest coverage of 1.8x leaves minimal cushion for debt service in economic downturns
- Minimal equity base creates refinancing risk and limits financial flexibility for acquisitions or downturns
- Net income flat YoY (+0.0%) despite 20.2% revenue growth suggests margin compression or one-time items
- High insider trading activity (22 Form 4 filings in 90 days) warrants monitoring for potential concerns
- Debt/Equity of 6.68x and long-term debt of $1.30B create significant balance sheet risk
- Interest coverage of 1.8x leaves limited cushion if earnings soften or borrowing costs remain elevated
- Net income was flat YoY despite strong revenue growth, suggesting earnings quality and margin durability need scrutiny
Key Metrics to Watch
- Debt-to-equity ratio trending - critical threshold is maintaining below 5.0x
- Interest coverage ratio improvement - needs to exceed 2.5x for safety
- Operating margin sustainability - watch for margin compression in competitive markets
- Free cash flow growth relative to debt reduction - validate leverage improvement commitment
- Interest coverage and net debt reduction progress
- Net income growth and free cash flow margin versus revenue growth
Aveanna Healthcare Holdings, Inc. (AVAH) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The relatively thin 4.8% FCF margin may limit capital allocation flexibility.
AVAH Profit Margin, ROE & Profitability Analysis
AVAH vs Services Sector: How Aveanna Healthcare Holdings, Inc. Compares
How Aveanna Healthcare Holdings, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Aveanna Healthcare Holdings, Inc. Stock Overvalued? AVAH Valuation Analysis 2026
Based on fundamental analysis, Aveanna Healthcare Holdings, Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Aveanna Healthcare Holdings, Inc. Balance Sheet: AVAH Debt, Cash & Liquidity
AVAH Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Aveanna Healthcare Holdings, Inc.'s revenue has grown significantly by 36% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.06 indicates the company is currently unprofitable.
AVAH Revenue Growth, EPS Growth & YoY Performance
AVAH Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $509.0M | $14.1M | $0.06 |
| Q2 2025 | $505.0M | $2.7M | $0.01 |
| Q1 2025 | $490.7M | $5.2M | $0.03 |
| Q3 2024 | $478.0M | -$40.1M | $-0.21 |
| Q2 2024 | $471.9M | $2.7M | $0.01 |
| Q1 2024 | $466.4M | -$11.2M | $-0.06 |
| Q3 2023 | $443.0M | $24.3M | $0.13 |
| Q2 2023 | $443.0M | -$6.4M | $-0.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Aveanna Healthcare Holdings, Inc. Dividends, Buybacks & Capital Allocation
AVAH SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Aveanna Healthcare Holdings, Inc. (CIK: 0001832332)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AVAH
What is the AI rating for AVAH?
Aveanna Healthcare Holdings, Inc. (AVAH) has a Combined AI Rating of HOLD from Claude (HOLD) and ChatGPT (HOLD) with 69% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AVAH's key strengths?
Claude: Strong revenue growth of 20.2% YoY indicating market expansion in home healthcare. Solid profitability with 33.3% gross margin and 10.2% operating margin showing pricing power. ChatGPT: Revenue growth of 20.2% YoY with positive operating leverage. Gross margin of 33.3% and operating margin of 10.5% indicate a profitable core business.
What are the risks of investing in AVAH?
Claude: Dangerously high leverage at 6.68x debt-to-equity ratio with $1.3B long-term debt against $194.5M equity. Weak interest coverage of 1.8x leaves minimal cushion for debt service in economic downturns. ChatGPT: Debt/Equity of 6.68x and long-term debt of $1.30B create significant balance sheet risk. Interest coverage of 1.8x leaves limited cushion if earnings soften or borrowing costs remain elevated.
What is AVAH's revenue and growth?
Aveanna Healthcare Holdings, Inc. reported revenue of $2.4B.
Does AVAH pay dividends?
Aveanna Healthcare Holdings, Inc. does not currently pay dividends.
Where can I find AVAH SEC filings?
Official SEC filings for Aveanna Healthcare Holdings, Inc. (CIK: 0001832332) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AVAH's EPS?
Aveanna Healthcare Holdings, Inc. has a diluted EPS of $1.05.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is AVAH a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Aveanna Healthcare Holdings, Inc. has a HOLD rating with 69% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is AVAH stock overvalued or undervalued?
Valuation metrics for AVAH: ROE of 115.7% (sector avg: 16%), net margin of 9.2% (sector avg: 10%). Higher ROE suggests strong returns relative to peers.
Should I buy AVAH stock in 2026?
Our dual AI analysis gives Aveanna Healthcare Holdings, Inc. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is AVAH's free cash flow?
Aveanna Healthcare Holdings, Inc.'s operating cash flow is $125.9M, with capital expenditures of $8.8M. FCF margin is 4.8%.
How does AVAH compare to other Services stocks?
Vs Services sector averages: Net margin 9.2% (avg: 10%), ROE 115.7% (avg: 16%), current ratio 1.32 (avg: 1.5).
Is Aveanna Healthcare Holdings, Inc. carrying too much debt?
AVAH has a debt-to-equity ratio of 6.68x, which is above the Services sector average of 0.7x. However, the current ratio of 1.32 suggests adequate short-term liquidity.
Why is AVAH's return on equity (ROE) so high?
Aveanna Healthcare Holdings, Inc. has a return on equity of 115.7%, significantly above the Services sector average of 16%. A high ROE indicates the company is efficient at generating profits from shareholder equity. This is supported by a 9.2% net margin.